PARATEK PHARMACEUTICALS INC's ticker is and the CUSIP is 699374AB0. A total of 16 filers reported holding PARATEK PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,157,000 | – | 1,600,000 | – | 0.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PenderFund Capital Management Ltd. | 20,060,000 | $22,462,000 | 6.07% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 29,590,000 | $23,376,000 | 1.99% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 27,750,000 | $22,339,000,000 | 0.49% |
| AQR Arbitrage LLC | 3,050,000 | $2,491,000 | 0.11% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,950,000 | $3,197,000 | 0.10% |
| Teton Advisors, Inc. | 400,000 | $323,000 | 0.05% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 6,500,000 | $5,309,000 | 0.04% |
| MACQUARIE GROUP LTD | 11,329,000 | $5,922,000 | 0.01% |
| GABELLI FUNDS LLC | 750,000 | $606,000 | 0.01% |
| WELLS FARGO & COMPANY/MN | 4,000,000 | $3,184,000 | 0.00% |